Figure 8.Chemotherapy sensitivity and immunotherapy response assessment. (A–I) IC50 of nine kinds of chemotherapy drug between high- and low-risk groups. (J–M) Immunotherapy response prediction based on Tumor Immune Dysfunction and Exclude module.
Figure 8 — Comprehensive analyses reveal the prognosis and biological function roles of chromatin regulators in lung adenocarcinoma | Aging
